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Abstract
Background: Estrogen deficiency is thought to be responsible for the higher frequency of aneurysmal subarachnoid
hemorrhage in post- than premenopausal women. Estrogen replacement therapy appears to reduce this risk but is
associated with significant side effects. We tested our hypothesis that bazedoxifene, a clinically used selective estrogen
receptor (ER) modulator with fewer estrogenic side effects, reduces cerebral aneurysm rupture in a new model of
ovariectomized rats.
Methods: Ten-week-old female Sprague-Dawley rats were subjected to ovariectomy, hemodynamic changes,
and hypertension to induce aneurysms (ovariectomized aneurysm rats) and treated with vehicle or with 0.3
or 1.0 mg/kg/day bazedoxifene. They were compared with sham-ovariectomized rats subjected to hypertension and
hemodynamic changes (HT rats). The vasoprotective effects of bazedoxifene and the mechanisms underlying its
efficacy were analyzed.
Results: During 12 weeks of observation, the incidence of aneurysm rupture was 52% in ovariectomized rats. With no
effect on the blood pressure, treatment with 0.3 or 1.0 mg/kg/day bazedoxifene lowered this rate to 11 and
17%, almost the same as in HT rats (17%). In ovariectomized rats, the mRNA level of ERα, ERβ, and the tissue
inhibitor of metalloproteinase-2 was downregulated in the cerebral artery prone to rupture at 5 weeks after
aneurysm induction; the mRNA level of interleukin-1β and the matrix metalloproteinase-9 was upregulated. In
HT rats, bazedoxifene restored the mRNA level of ERα and ERβ and decreased the level of interleukin-1β and
matrix metalloproteinase-9. These findings suggest that bazedoxifene was protective against aneurysmal rupture by
alleviating the vascular inflammation and degradation exacerbated by the decrease in ERα and ERβ.
Conclusions: Our observation that bazedoxifene decreased the incidence of aneurysmal rupture in ovariectomized rats
warrants further studies to validate this response in humans.
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Background
The rupture of cerebral aneurysms elicits devastating
subarachnoid hemorrhage (SAH). Surgical and endovas-
cular treatments can be preventive but are associated
with inherent risks and complications [1]. Therefore,
medical therapy with lower risks for complications is
needed to prevent SAH.
The incidence of cerebral aneurysms and SAH is
higher in post- than premenopausal women [2, 3]. Post-
menopausal estrogen deficiency is thought to play a key
role in the pathophysiology of cerebral aneurysms. Our
group established a cerebral aneurysm model in ovariecto-
mized rats subjected to hemodynamic stress and hyper-
tension [4]. The model mimics human postmenopausal
hormonal conditions. Estrogen-deficient model rats had a
higher incidence of cerebral aneurysms than male rats,
and estrogen deficiency promoted endothelial damage and
vascular inflammation [5–8]. Estrogen (17β-estradiol) and
an estrogen receptor β (ERβ)-, but not an ERα agonist, re-
duced the incidence of cerebral aneurysm rupture in
ovariectomized mice [9]. These findings suggest that ER-
related drugs may help to prevent SAH. In humans,
postmenopausal estrogen replacement therapy reduced
the risk of SAH [10–12] but increased the risk for breast
and endometrial cancer, stroke, and venous thrombo-
embolism [9, 13–15].
Bazedoxifene (BZA), a selective estrogen receptor
modulator (SERM), is used to prevent postmenopausal
osteoporosis. It has fewer estrogenic side effects than
conjugated estrogen. SERM is a ligand of ERα and ERβ;
its characteristics are different from pure ER agonists
and ER-antagonists because, depending on the target
tissue, it exerts agonistic or antagonistic effects [16]. Its
tissue-specific effects are thought to be attributable to its
distinct affinity for each ER, a unique conformational
change in ERs upon binding to SERM, and the distinct
distribution of ERα and ERβ in the tissue [16, 17].
Therefore, we used our rat model to investigate whether
BZA may represent a potential and safer prophylactic
agent against cerebral aneurysm rupture in postmeno-
pausal women.
We established a novel rat model of aneurysm rupture
by modifying the carotid ligation procedure used in our
original model in which ovariectomized rats were
subjected to hemodynamic changes and hypertension
without pharmacologically elicited degeneration of the
arterial wall [18]. The pathological features of the experi-
mental aneurysms in our ovariectomized hypertensive rats
were those of human aneurysms. In the posterior cerebral
artery (PCA) where ruptured aneurysms formed most
frequently, the mRNA level of interleukin (IL)-1β was
higher and the imbalance of matrix metalloproteinase
(MMP)-9 and the level of the tissue inhibitor of
metalloproteinase-2 (TIMP-2) were greater than at the
bifurcation of the anterior cerebral artery-olfactory artery
(ACA-OA) where no ruptured aneurysms were observed.
We suggested that these molecules associated with inflam-
mation and vascular degradation are at least partly
responsible for aneurysmal rupture [18]. Here, we used
our modified rat aneurysm model to test the hypothesis
that BZA exerts protective effects against vascular inflam-
mation and aneurysm rupture.
We now demonstrate that BZA reduced the incidence
of aneurysmal rupture without affecting the blood
pressure in ovariectomized aneurysm-model rats. Its
restoration of the decreased expression of both ERs in the
aneurysm-prone cerebral artery was associated with the
reduction of pro-inflammatory cytokines and vascular
degradation molecules. We also show that BZA attenu-
ated the body weight gain seen under conditions of
estrogen deficiency and hypertension. Our findings
suggest BZA as a potential therapeutic agent for the
prevention of SAH in postmenopausal women.
Methods
Animals
Sexually mature (10-week-old) [19] female Sprague-Dawley
rats (220–250 g, n = 137; Charles River Laboratories Japan
Inc., Yokohama, Japan) were housed under specific-
pathogen-free conditions and controlled temperatures
(23 ± 2 °C), humidity (55 ± 10%), and light (12-h light/dark
cycle, 8 am–8 pm). Food and water were ad libitum.
Cerebral aneurysm induction
Cerebral aneurysms were induced by hypertension (renal
artery ligation and a high-salt diet), increased hemodynamic
changes (carotid artery ligation), and estrogen deficiency
(bilateral ovariectomy) as described elsewhere [18].
We ligated the right external carotid and the pterygo-
palatine artery and the left common carotid artery.
The rats were bilaterally ovariectomized immediately
after carotid ligation and then fed a high-salt diet (8%
sodium chloride). Two weeks later, the bilateral
posterior renal arteries were ligated.
Experimental study 1
To assess whether ovariectomy increases and BZA
treatment reduces the incidence of cerebral aneurysm
rupture in hypertensive ovariectomized rats, 84 rats were
randomly assigned to three groups (each group n = 28).
One group was treated with vehicle (HT+OVX); the
other two groups received 0.3 or 1.0 mg/kg/day BZA
(BZA0.3, BZA1, respectively). Another set of 28 rats was
sham-ovariectomized, subjected to hypertension, exposed
to hemodynamic changes, and treated with vehicle (HT
rats). BZA was kindly provided by Pfizer Inc. (New York,
NY, USA). The BZA dose, determined based on an earlier
study [20], was suspended in 5% Arabic gum solution
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(BZA0.3 rats: 0.06 mg/ml, BZA1 rats: 0.2 mg/ml) and
perorally administered once a day (5 ml/kg for all
solutions) for 12 weeks by blinded investigators. The 5%
Arabic gum solution was also the vehicle. In our previous
study, cerebral aneurysms started to rupture approxi-
mately 30 days after their induction [18]. The administra-
tion of BZA and of vehicle was started 2 weeks after renal
artery ligation so that BZA would affect the rupture rather
than the formation of aneurysms.
Aneurysm rupture was suspected when the rats exhib-
ited neurologically abnormal behavior [21], developed a
significant weight loss (> 30 g/day, approximately 10% of
their body weight), or died. Rats with these findings were
sacrificed immediately, and their brains were inspected to
confirm SAH due to rupture of a cerebral aneurysm.
Blinded investigators recorded the body weight daily to
detect a sudden weight loss possibly indicative of
aneurysmal rupture, assessed the clinical signs, and
evaluated the brains. A representative ruptured aneurysm
at the left PCA is shown in Additional file 1: Figure S1. All
surviving rats were euthanized 12 weeks after aneurysm
induction, and their brains were inspected for the
presence of ruptured aneurysms. Data collection and
analysis were performed in blinded fashion.
Of the 112 rats, we excluded 14 (5 HT+OVX, 1 BZA0.3,
4 BZA1, and 4 HT rats) because there was no evidence of
rupture, although aneurysmal rupture was suspected.
Blood pressure measurements
To measure the blood pressure, the rats were placed on a
37 °C hot plate (Nissin, Tokyo, Japan) and covered with a
blanket. After they adapted to the environment, their
systolic blood pressure was measured twice, and the mean
value was recorded. Blood pressure measurements were
obtained immediately before and 2 and 12 weeks after
renal artery ligation by the tail-cuff, auto-pickup method
(Softron, Tokyo, Japan).
Experimental study 2
To analyze the molecular mechanisms underlying the
effects of ovariectomy and BZA on rat cerebral
aneurysms, we performed quantitative real-time PCR
(qRT-PCR) to assess the gene expression level and
immunohistochemical staining to determine the protein
expression level in the cerebral artery.
qRT-PCR assay
Another set of 21 rats was randomly divided into three
equal groups of HT+OVX, BZA1, and HT rats.
Bazedoxifene or vehicle was administered as in the
“Experimental study 1” section. We did not prepare a
BZA0.3 group because experimental study 1 had shown
that the incidence of cerebral aneurysm rupture was not
significantly different between BZA0.3 and BZA1 rats.
To avoid excluding rats that would develop aneurysmal
rupture, we euthanized these rats at 5 weeks after renal
ligation before their experimentally induced aneurysms had
begun to rupture in experimental study 1. We collected
tissue samples from these 21 rats from the left proximal
PCA (between the basilar bifurcation and the posterior
communicating artery) where ruptured cerebral aneu-
rysms had formed most frequently in HT+OVX rats in
experimental study 1.
After transcardial perfusion with normal saline, we
removed the left PCA. Total RNA was extracted with
the MagNA Pure RNA isolation kit (Roche, Tokyo,
Japan) and placed in a MagNA lyser (Roche). We used
Transcriptor Universal cDNA Master (Roche) for the
reverse transcription of total RNA to cDNA and a
LightCycler 2.0 (Roche Diagnostics, Tokyo, Japan) for
qRT-PCR. LightCycler FastStart DNA Master and SYBR
Green I (Roche) were used for glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), ERα, ERβ, IL-1β, IL-6, tumor
necrosis factor-α (TNF-α), MMP-9, and TIMP-2. The
primers were as follows: for GAPDH, forward (F), 5′-TAC
ACT GAG GAC CAG GTT G-3′, reverse (R), 5′-CCC
TGT TGC TGTAGC CATA-3′; for ERα, F, 5′-TGC ACC
ATC GAT AAG AAC C-3′, R, 5′-GTC TCC TGA AGT
GCC CAT T-3′; for ERβ, F, 5′-CTG CAT GGC TGA
GCG ACA A-3′, R, 5′-AGA GAC TCA TGG GAC TCA
GAT-3′; for IL-1β, F, 5′-TGC AGG CTT CGA GAT GAA
C-3′, R, 5′-AGC TCA TGG AGA ATA CCA CTT G-3′;
for IL-6, F, 5′-TCT CAG GGA GAT CTT GGA AAT G-3′,
R, 5′-TAG AAA CGG AAC TCC AGA C-3′; for TNF-α, F,
5′-CCC AAC AAG GAG AAG T-3′, R, 5′-CGC TTG
GTG GTT TGC TAC-3′; for MMP-9, F, 5′-CCT GGA
ACT CAC ACA ACG-3′, R, 5′-GAG GTC ATA GGT
CAC GTA GG -3′; and for TIMP-2, F, 5′-CCC TCT GTG
ACT TTA TTG TGC-3′, R, 5′-TGA TGC TCT CTG
TGA CC-3′. The PCR conditions were 95 °C for 10 min
followed by 40 cycles at 95 °C for 10 s, 60 °C for 10 s, and
72 °C for 8 s. We subjected samples from each group to
two independent qRT-PCR assays to determine the gene
expression level. The results were quantified after
normalization to the expression of GAPDH mRNA. To
assess the effect of BZA on the uterus, we collected the
uterus and measured its weight.
Immunohistochemical staining
The left proximal PCA from two HT+OVX and two
BZA1 rats was collected 5 weeks after renal ligation to
confirm ER protein expression in the arterial wall. After
perfusion with 4% paraformaldehyde, the left PCA was
harvested, immersed in 4% paraformaldehyde (24 h at
4 °C), and successively dehydrated in 10, 20, and 30%
sucrose. The arteries were rinsed with phosphate-buffered
saline, embedded in OCT compound (Tissue-Tek Inc.),
and cut into 5-μm thick serial sections with a cryotome
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(CM 1850; Leica). After 30-min serum-free protein block-
ade (Dako, Carpinteria, CA, USA), primary antibodies
against ERα and ERβ (Santa Cruz Biotechnology, CA,
USA) diluted 1:100 with Canget signal immunostain
(Toyobo, Osaka, Japan) were added for overnight incuba-
tion at 4 °C. Sections not treated with the primary
antibodies were the negative control. All sections
were then incubated for 1 h at room temperature
with fluorescein-conjugated secondary antibodies
Alexa Fluor 594 (Molecular Probes, CA, USA) in
Canget signal immunostain (1:800 dilution, Toyobo),
mounted with Vectashield (Vector Laboratories, CA,
USA), and examined under a fluorescence microscope
(KEYENCE, BZ-X710, Osaka, Japan).
Statistical analysis
For sample-size calculation, we implemented α = 0.05 and
1-β = 0.8 with an effect size of 0.4 (literature-based) [9]
using G*Power 3.1 (University of Düsseldorf, Düsseldorf,
Germany), indicating that 25 samples per group were
required. Expecting a loss of 10–15% of the rats, we used
28 animals per group in experimental study 1. Statistical
analyses were performed with SPSS 22 (IBM Armonk,
NY). Fisher’s exact test was used to analyze the incidence
of cerebral aneurysm rupture. Sequentially, obtained data
(mean ± SD) were analyzed with analysis of variance
(ANOVA) followed by Scheffe’s test for multiple group
comparisons of the mRNA level. Differences were consid-
ered statistically significant at p < 0.05.
Results
BZA prevents aneurysmal rupture in rats
To determine whether estrogen deficiency increases while
BZA decreases the incidence of cerebral aneurysm rupture
in estrogen-deficient rats, we compared the incidence of
rupture during 12 weeks of observation in hypertensive
ovariectomized aneurysm rats treated with vehicle (HT
+OVX), 0.3 mg/kg BZA (BZA0.3), or 1 mg/kg BZA
(BZA1) and in hypertensive sham-ovariectomized rats
(HT rats) (for their preparation see the “Experimental
study 1” section). The treatments were started 2 weeks
after bilateral renal ligation and continued throughout the
12-week observation period.
As shown in Fig. 1a, HT+OVX rats manifested a
significantly higher incidence of cerebral aneurysm
rupture than HT rats (52 vs 17%, p < 0.05). BZA
treatment decreased the incidence of rupture (BZA0.3,
11%; BZA1, 17%; each p < 0.05 vs HT+OVX rats).
Notably, the rate of aneurysmal rupture in BZA0.3 and
BZA1 rats was similar to that in HT rats, suggesting that
the effect of BZA was not dose-dependent. BZA did not
affect the systolic blood pressure, which was elevated
after renal ligation (Fig. 1b). These results suggest that
estrogen deficiency promoted aneurysm rupture in the
presence of hypertension, while BZA inhibited its effect
in a blood pressure-independent manner. Most ruptured
aneurysms had arisen in the PCA (64%); 14% each were
found in the internal carotid or the anterior cerebral
artery (14%), and 9% in the middle cerebral artery.
Although there was no significant difference in the body
weight at the time of randomization [HT, 251.8 ± 16.2 g;
HT+OVX, 260.9 ± 22.7 g; BZA0.3, 261.0 ± 16.4 g; BZA1,
263.7 ± 12.7 g (mean ± SD)], 12 weeks after aneurysm
induction, the body weight of HT+OVX rats was signifi-
cantly greater than that of HT rats (381.4 ± 27.6 vs
300.2 ± 18.8 g, p < 0.05). The body weight of BZA1 was
significantly lower than that of HT+OVX rats
(263.7 ± 12.7 g vs 335.3 ± 17.3 g); treatment with 0.3 mg/
kg BZA did not affect the body weight (375.8 ± 24.4 g)
(Fig. 1c). In addition, 5 weeks after aneurysm induction,
the wet uterine weight of HT+OVX rats was significantly
lower than that of HT rats; it was similar in BZA1 and HT
Fig. 1 a Incidence of aneurysm rupture within 12 weeks after aneurysm induction (*p < 0.05, Fisher’s exact test). b Sequential changes in the
systolic blood pressure (*p < 0.05 vs sham, Scheffe’s test). c The body weight at 12 weeks after aneurysm induction (*p < 0.05, Scheffe’s test). Data
are the mean ± SD. n = 23 – 27 per group
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+OVX rats (HT, 440.5 ± 48.1 mg; HT + OVX,
145.5 ± 21.1 mg; BZA0.3, 261.0 ± 16.4 mg; BZA1,
134.7 ± 13.1 mg; mean ± SD; see Additional file 2: Figure
S2]) The incidence of aneurysmal rupture and the body
weight in BZA1 and HT rats were similar, suggesting that
1 mg/kg BZA revoked the effect of estrogen deficiency on
the vasculature and the body weight without increasing
the uterine weight.
BZA upregulates ERα and ERβ expression in the cerebral
artery
As BZA is a SERM acting on ERs, we next investigated
how treatment with BZA affected the ER expression in
the cerebral artery of estrogen-deficient rats. Five weeks
after bilateral renal ligation, we assessed the mRNA level
and the protein expression of ERs in the left PCA where
ruptured aneurysms had formed most frequently in
experimental study 1.
HT+OVX rats exhibited significantly lower mRNA
levels of ERα and ERβ than did HT rats with intact
ovaries. In BZA1 rats, the mRNA level of both ERα and
ERβ was significantly elevated and was similar to the
level in HT rats (Fig. 2a). In agreement with the mRNA
level of ERs, ERα, and ERβ, protein expression was low
in the cerebral arteries of HT+OVX rats. In BZA1 rats,
the expression of both ERα and ERβ was greater than in
HT+OVX rats (Fig. 2b). These findings indicate that
BZA restored the gene and protein expression of both
ERα and ERβ that was decreased by estrogen deficiency.
BZA downregulates IL-1β and decreases the MMP-9/TIMP-2
ratio in the cerebral artery
Elsewhere, we demonstrated that aneurysmal rupture in
ovariectomized hypertensive rats was associated with the
increase in the mRNA level of IL-1β and the MMP-9/
TIMP-2 ratio in the aneurysmal wall [18, 22]. Here, we
examined the mRNA level of IL-1β, IL-6, TNF-α, MMP-9,
and TIMP-2 to explore the mechanisms underlying the
protective effects of BZA against aneurysmal rupture.
The IL-1β mRNA level was significantly higher in HT
+OVX than HT rats. In BZA1 rats, the level of IL-1β
was significantly decreased and similar to the level in
HT rats (Fig. 3a). The mRNA level of IL-6 was similar
among HT, HT+OVX, and BZA1 rats (Fig. 3b). On the
other hand, the mRNA level of TNF-α was significantly
increased in HT+OVX rats, and while it was lower in
BZA1 rats, the difference did not reach statistical sig-
nificance (Fig. 3c). These findings suggest that the gene
expression of IL-1β and TNF-α, but not of IL-6, is reg-
ulated at least partly by ERs.
The mRNA level of MMP-9 was significantly higher in
HT+OVX than HT rats. In contrast, the mRNA level of
TIMP-2 was lower in HT+OVX than HT rats. The
mRNA level of MMP-9 in BZA1 rats was significantly
lower, and TIMP-2 was higher than in HT+OVX rats
(Fig. 4a, b). Consequently, the MMP-9/TIMP-2 ratio was
reduced in BZA1 rats (Fig. 4c). These observations
suggest that elevated MMP-9 mRNA- and attenuated
TIMP-2 mRNA expression are associated with the
downregulation of ERs. The downregulation of IL-1β
Fig. 2 a mRNA level of estrogen receptor (ER)α and ERβ at the left posterior cerebral artery. The level was determined by quantitative real
time-PCR and normalized by the glyceraldehyde 3-phophate dehydrogenase (GAPDH) mRNA level. n = 7 per group, *p < 0.05 (Scheffe’s test).
Data are the mean ± SD. b Immunohistochemical staining for ERα and ERβ in the left posterior cerebral artery
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and the amelioration of the MMP/TIMP2 ratio via the
modulation of ERs by BZA may have contributed to the
prevention of aneurysmal rupture in our estrogen-
deficient hypertensive rats.
Discussion
We demonstrate that ovariectomy promoted aneurysmal
rupture in hypertensive rats subjected to hemodynamic
stress. We first document that in our hypertensive,
ovariectomized aneurysm-model rats, the downregula-
tion of ERs and the upregulation of pro-inflammatory
molecules in the rupture-prone cerebral artery were
associated with an increase in the aneurysmal rupture
rate and that BZA ameliorated the downregulation of
ERs, restored their gene and protein expression,
decreased the incidence of aneurysmal rupture, and
lowered the level of pro-inflammatory- and vascular
degradation molecules. The incidence of ruptured aneu-
rysms and the mRNA level of ERs and pro-inflammatory
and vascular degradation molecules were similar to those
in HT rats with intact ovaries. These findings suggest that
BZA prevented aneurysmal rupture associated with
inflammation and vascular degradation via the downregu-
lation of ERs in our ovariectomized aneurysm-model rats.
Estrogen exerts diverse vascular effects mediated mainly
by ERα and ERβ [23]. The treatment of ovariectomized
rats with estradiol reversed the decrease in ERα and ERβ
expression in the cerebral vessel wall [19]. Using our
original aneurysm model, we demonstrated that estrogen
deficiency elicited by ovariectomy reduced the expression
of ERα while the expression of ERβ was retained at the
bifurcation of the ACA-OA where unruptured aneurysms
were highly and reproducibly induced [6]. The present
study showed that the expression of ERα and ERβ in the
PCA prone to aneurysmal rupture was reduced in our
ovariectomized aneurysm rats and that BZA upregulated
both ERα and ERβ in the PCA. Elsewhere, our group
documented that in ovariectomized aneurysm mice, treat-
ment with estrogen or an ERβ-, but not an ERα agonist,
reduced the incidence of cerebral aneurysm rupture [9].
The downregulation of ERβ is thought to be associated
with inflammation [24]. We suggest now that in our
current rat aneurysm model, BZA exerted protective
effects against rupture through ERβ stimulation.
IL-1β promotes extracellular matrix degradation by
increasing the production of MMPs and decreasing the
production of TIMPs [25, 26]. TNF-α and IL-6 also
stimulate the expression of MMP-9 [27, 28]. In our
current and earlier studies [18, 22], the increase in IL-1β
and TNF-α and the imbalance between MMP-9 and
TIMP-2 were associated with aneurysm rupture in
ovariectomized aneurysm rats. BZA abated the increase
in IL-1β and the imbalance between MMP-9 and TIMP-2
and resulted in a moderate inhibition of TNF-α. ERβ
stimulation decreased cellular inflammasome activity and
IL-1β expression after global cerebral ischemia in
Fig. 3 mRNA level of (a) interleukin (IL)-1β, (b) IL-6, (c) tumor necrosis factor (TNF)-α in the left posterior cerebral artery. The levels were deter-
mined by quantitative real time-PCR and normalized by the glyceraldehyde 3-phophate dehydrogenase (GAPDH) mRNA level. *p < 0.05 (Scheffe’s
test). Data are the mean ± SD. n = 7 per group
Fig. 4 mRNA level of (a) matrix metalloproteinase (MMP)-9 and (b) tissue inhibitor of metalloproteinase (TIMP)-2 in the left posterior cerebral
artery. The levels were determined by quantitative real time-PCR and normalized by the glyceraldehyde 3-phophate dehydrogenase (GAPDH)
mRNA level. c Ratio of the MMP-9/TIMP-2 mRNA level. *p < 0.05 (Scheffe’s test). Data represent the mean ± SD. n = 7 per group
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ovariectomized rats [24]. Selective ERβ agonists repress
the transcription of pro-inflammatory genes including
TNF-α [29]. The ERβ agonistic effects of BZA may be re-
sponsible for the downregulation of pro-inflammatory cy-
tokines, resulting in the inhibition of vascular degradation.
Others reported that TNF-α modulates cerebral
aneurysm formation and rupture. The TNF-α inhibitor
3,6’dithiothalidomide resulted in aneurysmal stabilization
and a significant decrease in the rupture rate [30]. In
contrast, a meta-analysis reiterated that IL-6 was not
associated with the pathogenesis of intracranial aneurysms
[31]. These studies support our present findings.
In women, ERα activation in the brain stimulated
physical activity and reduced their food intake and body
weight gain [32, 33]. Therefore, the effect of BZA at
1 mg/kg, but not 0.3 mg/kg, on the body weight of our
rats may have involved the upregulation of ERα. On the
other hand, since ERβ is thought to be associated with
vasoprotection, the effect of BZA on the body weight via
the upregulation of ERα may be smaller than the
vasoprotective effects elicited by ERβ. Estradiol and a
selective ERα agonist increased the uterine weight in
mice [15]. However, BZA had no such effects in the
current and an earlier study [20], indicating that its
effects are tissue-specific.
Use of our original rat aneurysm model resulted in a
high incidence (more than 80%) of unruptured
aneurysms at the ACA-OA bifurcation; at most, 10% of
these aneurysms ruptured during the 12-week observa-
tion period. For the current study, we modified the
hemodynamics of our original model and produced a
novel model in which approximately 50% of the experi-
mentally induced aneurysms spontaneously ruptured
[18]. With this new model, we demonstrated the
protective effect of BZA, a selective ER modulator, on
cerebral aneurysm rupture. The efficacy for prevention
of aneurysm rupture may provide a new therapeutic
option in the clinical setting.
Our study has some limitations. First, we assessed the
changes in the mRNA level and the protein expression
of the ERs elicited by ovariectomy and BZA. For a better
understanding of the effects of individual ERs, studies
using specific ER agonists or inhibitors and knockout
animal are needed. Second, we started the administra-
tion of BZA 2 weeks after aneurysm induction without
confirming the presence of cerebral aneurysms, and we
did not confirm the presence of unruptured aneurysm in
rupture-prone arteries at 12 weeks. Therefore, it is
unclear whether BZA prevented their formation or their
rupture. Third, the rodent age may affect their vascular
response to estrogen [34], and menopause simulated by
ovariectomy in our rats may be different from natural
menopause in aged rats. Further studies are underway to
address these questions.
Conclusions
This is the first study to show that BZA exerted protect-
ive effects against aneurysmal rupture in hypertensive
ovariectomized aneurysm rats without affecting their
blood pressure. It ameliorated the downregulation of
ERs, the upregulation of IL-1β, and the MMP-9/TIMP-2
imbalance in the cerebral artery. Since BZA has fewer
estrogenic side effects than estrogen and is clinically
used to address osteoporosis, it may help to prevent
SAH in postmenopausal women.
Additional files
Additional file 1: Figure S1. A ruptured aneurysm in the left posterior
cerebral artery (PCA) of an OVX/VC rat (arrowhead). (TIFF 4425 kb)
Additional file 2: Figure S2. Wet uterine weight 5 weeks after
aneurysm induction. *p < 0.05 (Scheffe’s test). Data represent the
mean ± SD. n = 7 per group. (TIFF 2286 kb)
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